Protara Therapeutics, Inc.
- TARA
- NASDAQ
- Biotechnology
- Oncology Therapies
- Rare Disease Drugs
$2.38
Today +2.55%Quote Oct 19, 2026, 07:40 PM UTC
−37.30%over the last month
Max drawdown −37.3%From 1-month high −37.3%3 months −43.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Protara Therapeutics
Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
46
Market value
$140.6M
Quote Oct 19
Analyst target
$12.00
+404.4% from here
Floor
$2.30
3.2% below price
Resistance
$2.41
1.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TARAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free